Cancer immunology Flashcards

1
Q

…………..is one of the tumor antigens and tumor markers that raised in ovarian cancer

A

CA125

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

…………ensures that lymphocytes specific for different antigens keep on moving from circulation to the peripheral lymphoid organs.

A

Lymphocytes recirculation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The stages of Immunoediting of cancer cells :

A

1-(Elimination) refers to effective immune surveillance for clones that express TSA.
2-(Equilibrium) refers to the selection for resistant clones (red).
3-(Escape ) refers to the rapid proliferation of resistant clones in the immunocompetent host.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

RAS protein which is normally [Active or inactive]

A

inactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

BRCA1, BRCA 2 are Mutated [oncogene/Tumor suppressor gene] products

A

Tumor suppressor gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

BCR/ABL Fusion proteins is Mutated [oncogene/Tumor suppressor gene] products

A

oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

HER2/NEU is Mutated [oncogene/Tumor suppressor gene] products

A

oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

RAS is Mutated [oncogene/Tumor suppressor gene] products

A

oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

WT genes is Mutated [oncogene/Tumor suppressor gene] products

A

Tumor suppressor gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BRCA1 & BRCA2: genes for……….. cancer

A

breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HER2/NEU is growth factor receptor usually seen in………. cancer and known as………..

A

1-breast
2-ERBB2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Example of Overexpression of normal proteins in the tumour antigen:

A

1-Tyrosinase, in melanoma
2-Cancer-testis antigens (CTA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

…………………. And ………………identified CTA ( Cancer-testis antigens) as ideal targets for tumor-specific …………….and……………..

A

1- The tumor-restricted pattern of expression and strong in vivo immunogenicity

2- immunotherapeutic and vaccine therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Examples of Cancer-testis antigens (CTA) is :

A

1-MAGE (Melanoma Antigen Gene) family of genes
2- BAGE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tumor Antigens include products of

A

1- mutated proto-oncogenes and tumor suppressor genes .
2-Mutated self proteins.
3- overexpressed or aberrantly expressed proteins.
4- viral oncogenic antigens.
5-onco-fetal antigens.
6- altered glycolipids and glycoproteins.
7- cell type–specific differentiation antigens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Expressed during fetal (embryonic life), but normally are not expressed (silent)
during adult life.

A

Oncofetal antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What it is the cause of expression of the oncofetal antigens in the cell cancer ?

A

the adults there is a repression of these genes normally. In the
cancer cells, this repression is removed, what we call (de-repression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the types of oncofetal antigens ?

A
  1. Alpha Feto-Protein (AFP)
  2. Carcino-Embryonic Antigen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the difference between Alpha Feto-Protein (AFP) and Carcino-Embryonic Antigen ? ( areas of the cancer )

A
  1. Alpha Feto-Protein (AFP) in hepatocellular (Primary liver cell carcinoma)
    carcinoma and some germ cell tumors (ovarian and testicular tumors)
  2. Carcino-Embryonic Antigen in Colon, lung and other cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the difference between Alpha Feto-Protein (AFP) and Carcino-Embryonic Antigen ? ( areas of the cancer )

A
  1. Alpha Feto-Protein (AFP) in hepatocellular (Primary liver cell carcinoma)
    carcinoma and some germ cell tumors (ovarian and testicular tumors)
  2. Carcino-Embryonic Antigen in Colon, lung and other cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the difference between Alpha Feto-Protein (AFP) and Carcino-Embryonic Antigen ? ( areas of the cancer )

A
  1. Alpha Feto-Protein (AFP) in hepatocellular (Primary liver cell carcinoma)
    carcinoma and some germ cell tumors (ovarian and testicular tumors)
  2. Carcino-Embryonic Antigen in Colon, lung and other cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

We can detect B cell lymphoma by their expression of…………

A

CD20

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Example of Cell type specific differentiation proteins in tumor antigen is :

A

CD-20 in B cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

CD-20 in B cell lymphoma is example of :

A

Cell type specific differentiation proteins in tumor antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Examples of Altered Cell Surface Glycolipids and Glycoproteins are :
Glycolipids : Gangliosides, Glycoproteins : blood group antigens + mucins (CA-125 and CA-19-9, expressed on ovarian carcinomas & MUC-1, on breast carcinomas)
26
The most important cells in killing tumor and tumor associating cells and in determining the effective immunity against tumor cell are………………
CD8+ t lymphocyte
27
Driver mutations /Passenger mutations in oncogenes and tumor suppressor genes that initiate transformation and confer growth self-sufficiency
Driver mutations
28
Driver mutations /Passenger mutations due to genetic instability that confer hallmarks of cancer and survival advantage.
Passenger
29
*We can find Cancer-testis antigens (CTA) in the ………. And ……. * if these genes get expressed in cells other than testis and placenta = …….………
1- testis 2- placenta. 3- tumor
30
………………….. is a tumor marker for hepatocellular carcinoma and some germ cell tumors (ovarian and testicular tumors) …………………..is a tumor marker for colon and lung cancer. *Hint: the answers are Oncofetal antigens
Alpha Feto-Protein (AFP) Carcino-Embryonic Antigen
31
The CD20 antigen is restricted to B cells. Its expression starts at the…….. of B cell ontogeny and continues until the………… stage. CD20 is not expressed on either precursor lymphoid cells or in the vast majority of plasma cells
1- pre-B stage 2- immunoblast
32
…………is a monoclonal (anti CD20) that we can use to treat CD20 in B cell lymphoma.
Rituximab
33
CA-125 is important for diagnosis and prognosis for……….. cancer
ovarian
34
MUC-1 expressed on ……………
on breast carcinomas
35
…………and………..expressed on ovarian carcinomas
1-CA-125 2- CA-19-9
36
Hepatitis B virus leads to ………….
Hepatocellular carcinoma
37
Human papillomavirus leads to …………..
Cervical cancer and other anogental neoplasm
38
Human Herpesvirus 8 (HHV8) leads to …….
Kaposi’s sarcoma
39
Epstein Barr virus ( EBV) leads to ……….
1-Nasopharyngeal carcinoma 2- Hodgkin’s lymphoma 3- Burkitt’s lymphoma 4- Lymphomas
40
Merkel cell polyomavirus (MCPyV) leads to ………..
Merkel cell carcinoma
41
Human T-cell lymphoma virus leads to ……….
Adult T-cell lymphoma/ leukaemia
42
…………… proteins in EBV-induced Lymphoma
EBNA
43
Antigens derived from inside the cell called ………………. antigens. processed and presented by………………. pathway ➡️ recognized by…………….
1-endogenous 2- MHC 1 3- CD8+ cells
44
Antigens derived from outside the cell are ……….. antigens. processed and presented by……………. pathway
1- exogenous 2- MHC 2
45
We have two types of responses - The……… against endogenous and intracellular proteins. - The ………response is against exogenous proteins. - The tumor antigens are produced inside the cells and against such cells so we need………….. response
1- CTL (CD+8) 2- T helper cell 3- CTL
46
………….recognize only protein antigens, while ………….recognize proteins, carbohydrates,nucleic acid, lipids, …etc.
1-T-lymphocyte 2- B-lymphocyte
47
Presentation of tumor neoantigens with MHC class I molecules is ………..……..
(antigen cross-presentation)
48
For the activation of T lymphocyte, the activation signals are classified into three classifications What is the signal 1?
Signal 1 is engagement of MHC I antigen complex with TCR (T-cell receptors).
49
For the activation of T lymphocyte, the activation signals are classified into three classifications What is the signal 2 ?
Signal 2 is engagement of the costimulatory molecules CD28 on T-cell and B7 on the dendritic cells.
50
For the activation of T lymphocyte, the activation signals are classified into three classifications What is the signal 3 ?
Signal 3 cytokine release: 1-- perforin: a protein which produces perforation in the membrane. 2- - Granzyme: cytolytic enzymes thatproduces protein lysis and apoptosis.
51
CD8+ T lymphocytes expresses ………………..which has the same ligand of CD 28 (i.e., B7). Thus, B7 could bind with both …………and……….. If B7 binds with CD 28, it sends stimulatory signals and T cell will be……….. On the other hand, if B7 binds with CTLA-4, it will send …………….signals and T cell will be inactivated
1- CTLA-4 2-CD28 and CTLA-4. 3-activated 4- inhibitory
52
The difference between extracellular and intracellular ( regions of CAR-T Cell)
1- extracellular part : which is antibody directed against tumor antigen 2–intracellular domain that deliver activating signals.
53
Ø Tumors that fail to express MHC class I antigens cannot be recognized by……… cells, but may trigger…… cells. Ø NK cells recognize MHC I negative cells through…… proteins that bind with stress induced antigens on transformed cells.
1- T cells 2- NK cells ( Natural Killer Cells) 3- NKG2D
54
Lytic activity of NK cell is enhanced with………...
IL2
55
………..cells are particularly useful against tumor cells which stopped expressing MHC-1.
NK
56
Tumor cells decrease expression of MHC1 to escape CTLs, but then they get caught by…………
Natural Killer cells.
57
PD-1 (on CTL) and PD-L1 (on tumor cells) are important immune………. Inhibitors of……… function.
1-checkpoint 2- CTL (suppress CTL function )
58
Aberrantly expressed ( tumour antigens) are : 1- ……… 2- ……….
1- MAGE 2-BAGE
59
Human papilloma virus……….. and ………..proteins in the cervical carcinoma …………… proteins in the EBV induced lymphoma
1- E6 + E7 2- EBNA
60
…………… Cell-mediated immunity is the dominant antitumor mechanism in vivo
Cytotoxic T Lymphocytes
61
What are the function of Cytotoxic T Lymphocytes:
1-MHC-restricted CD8+ cells can kill autologous tumor cells 2-Protective role against virus-associated neoplasms (e.g., EBV induced Burkitt lymphoma, HPV-induced tumors).
62
steps of Immune reactions to cancers :
1- Presentation of tumor neoantigens with MHC class I molecules (antigen cross-presentation) 2- Recognition by antigen-specific CD8+ T cells 3- Activation, Proliferation and Differentiation into active CTLs 4- Homing to the site of the tumor 5- Recognition and killing of tumor cells. I
63
CD8+ T lymphocytes could be activated by………. and this activation could be enhanced by………….. CD4+ T lymphocyte will release…………….. which is an activator of CD8+ T lymphocyte and this is called antigen cross presentation.
1- dendritic cells 2- CD4+ T lymphocyte 3- interferon gamma (IFN-γ)
64
PD-1 on ………….and PD-L1 on ………is an important immune checkpoint. • PD-1, PD-L1 interaction leads to…………..
1-CTL 2-tumor cells 3- CTL unresponsiveness
65
………….: a protein which produces perforation in the membrane.
perforin
66
……………: cytolytic enzymes that produces protein lysis and apoptosis
- Granzyme
67
B7 can bind to both……. and………..
1-CD28 2-CTLA-4
68
When B7 binds to CD28, it transmits [stimulatory/ inhibitory] signals to the T cell, leading to T-cell [activation/ inactivation]. if B7 binds to CTLA-4, it sends [stimulatory/ inhibitory] signals, resulting in T-cell [activation/ inactivation]. . The binding of B7 to CTLA-4 acts as …………….
1- stimulatory 2- activation 3- inhibitory 4-inactivation 5- a regulatory mechanism to prevent excessive or prolonged T-cell activation.
69
So there are 2 immune checkpoints blockages that we are directing at to activate CTLs and prevent their blockage: 1- 2-
1. Anti-PD-1 Anti-PD-L1 monoclonal antibodies 2. And anti-CTLA-4 monoclonal antibodies
70
What is the function of CAR-T cells?
CAR-T helps T-cells attach to specific cancer cell antigen.
71
Patient………. are harvested and engineered to express chimeric antigen receptors (CAR).
CTLs
72
T cells, NK cells, and macrophages may collaborate in antitumor reactivity, because…………, secreted by T cells and NK cells, is a potent activator of macrophages
IFN-γ
73
Activated macrophages kill tumors by mechanisms similar to those used to kill microbes : 1 - ……………………. 2- or by secretion of………….
1- (production of reactive oxygen metabolites) 2- TNF
74
Tumor immune evasion mechanisms include :
1.Selective outgrowth of antigen-negative variants. 2- Loss or reduced expression of histocompatibility molecules MHC I genes. 3- Immunosuppression. 4. Antigen masking
75
The tumor cells can induce tumor suppression by different mechanisms (examples) :
ØProduce immunosuppressive cytokines like TGF-β. ØEngagement of the T cell inhibitory receptor, CTLA-4 ØActivation of regulatory T cells. ØMay express FasL that engages with Fas on immune cell and induce the apoptosis.
76
………….which is an inhibitory cytokine that inhibit the proliferation of lymphocytes. Therefore, they inhibit the immune response
TGF-β
77
Antigen masking: tumor cells can cover their surface with………. molecule which can prevent the binding of antigen specific immune cells.
1- glycocalyx
78
The cell surface tumor antigen may be hidden from the immune system by glycocalyx molecules such as……... This phenomenon is called………
1- sialic acid 2- antigen masking
79
…………….. Thick coat of external glycocalyx molecules, (sialic acid–containing mucopolysaccharides, than normal cells). *Access to immune cells is blocked
antigen masking